Review
Targeted anti-estrogens to treat and prevent diseases in women

https://doi.org/10.1016/1357-4310(96)88775-2Get rights and content

Abstract

The estrogen receptor has been successfully targeted with the anti-estrogen tamoxifen to treat all stages of breast cancer. Because tamoxifen is a partial agonist, it exhibits target-site specificity: it acts as an anti-estrogen in the breast to inhibit tumor growth, while exhibiting estrogenic effects on bones and lipid metabolism. Therefore, tamoxifen has the added benefit of maintaining bone density and reducing the risk of myocardial infarction in postmenopausal women.

However, undesirable side effects of tamoxifen preclude its use as a hormone replacement therapy for otherwise healthy women. New anti-estrogens are currently being developed that may prevent osteoporosis, breast and endometrial cancer, and reduce the risk of myocardial infarction.

References (35)

  • V.C. Jordan

    Hormone receptor assays: clinical usefulness in the management of carcinoma of the breast

    CRC Crit. Rev. Clin. Lab. Sci.

    (1988)
  • I.A. Jaiyesimi et al.

    Use of tamoxifen for breast cancer: twenty-eight years later

    J. Clin. Oncol.

    (1995)
  • V.C. Jordan

    The development of tamoxifen for breast cancer therapy

  • Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy

    Lancet

    (1992)

    Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy

    Lancet

    (1992)
  • V.C. Jordan

    Molecular mechanisms of antiestrogen action in breast cancer

    Breast Cancer Res. Treat.

    (1994)
  • D.A. Tonetti et al.

    Possible mechanisms in the emergence of tamoxifen-resistant breast cancer

    Anti-cancer Drugs

    (1995)
  • Cited by (32)

    • Prevention of quinone-mediated DNA arylation by antioxidants

      1999, Biochemical and Biophysical Research Communications
    • The role of estrogen receptor mutations in tamoxifen-stimulated breast cancer

      1997, Journal of Steroid Biochemistry and Molecular Biology
    View all citing articles on Scopus
    1

    Tel: +1 312 908 4148 Fax: +1 312 908 1372

    View full text